Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00126789
Recruitment Status : Terminated (Based on PK data, product did not meet requirement for further development.)
First Posted : August 4, 2005
Last Update Posted : June 5, 2012
Information provided by (Responsible Party):
ZARS Pharma Inc.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2007
  Actual Study Completion Date : July 2007